Q: I would appreciate your latest opinion on AAV? If you are not impressed with it, could you please suggest some competitors that you would choose instead? I wanted to use it for my TFSA. Thanks for your service.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Peter and His Wonder Team
AP is a small cap company in Pittsburg since 1929. Please give me your general assessment. I know they are in a 3 stage plan and has decent management. Do you think it has any merit as a contrarian play? Will they benefit from infrastructure spending even in a downturn?
Thanks...as usual!
AP is a small cap company in Pittsburg since 1929. Please give me your general assessment. I know they are in a 3 stage plan and has decent management. Do you think it has any merit as a contrarian play? Will they benefit from infrastructure spending even in a downturn?
Thanks...as usual!
-
Sylogist Ltd. (SYZ)
-
Enghouse Systems Limited (ENGH)
-
Enthusiast Gaming Holdings Inc. (EGLX)
-
CrowdStrike Holdings Inc. (CRWD)
-
Digital Turbine Inc. (APPS)
-
Dye & Durham Limited (DND)
-
CloudMD Software & Services Inc. (DOC)
-
Mitek Systems Inc. (MITK)
-
TELUS International (Cda) Inc. Subordinate Voting Shares (TIXT)
Q: After selling ENGH yesterday, I am reviewing the above holdings and only want to keep stocks that have a potential to generate decent future income, over the next 5 years or may be acquired by another company. These are long-term holdings and I don't need the cash, but could use the tax loss. Don't want to sell any company with a positive future. Any of the above holdings that you would sell now?
Thanks!
Thanks!
Q: FANS ... seems a lot of insider buying .. your assessment of this company and is it a buy
Q: What does 5i thinks about this news with giant Dow Chemical and little EcoSynthetix?
MIDLAND, Mich., / USA – June 6, 2022 – Dow (NYSE: Dow) today announced an exclusive engagement with EcoSynthetix Inc. (TSX: ECO) to bring innovative bio-based, biodegradable and low-carbon solutions to the personal care industry. The engagement initially targets the hairstyling market, providing unmatched benefits for consumers. The engagement will enable both companies to leverage their key expertise by meeting the growing consumer demand for bio-based and biodegradable technologies that provide unique and high-performance benefits.
MIDLAND, Mich., / USA – June 6, 2022 – Dow (NYSE: Dow) today announced an exclusive engagement with EcoSynthetix Inc. (TSX: ECO) to bring innovative bio-based, biodegradable and low-carbon solutions to the personal care industry. The engagement initially targets the hairstyling market, providing unmatched benefits for consumers. The engagement will enable both companies to leverage their key expertise by meeting the growing consumer demand for bio-based and biodegradable technologies that provide unique and high-performance benefits.
Q: I have been considering an investment in SYZ to replace my MAL shares .... After reading your report and previous answers it looks to me like I would be getting a company with revenue growth in 2022 of 43% and for 2023 of 80% while collecting a juicy close to 7% dividend .... But a couple of things give me pause .... First Simply Wall Street { link included at the end of the question } claims earnings will decrease by 32.4% per year for the next three years . I am having a hard time reconciling how how revenue will have those lofty growth numbers while simutaneously earnings will decline rather nastily ..... Could you explain please ? And comment on the other risk factors Simply Wall Street cites ? .... Also in another recent question 5I commented that SYZ was susceptible to both inflation and recession more than a list of other companies the member asked about ..... Could you elaborate on that thesis ? .....Thanks for your great service ......
https://simplywall.st/stocks/ca/software/tsx-syz/sylogist-shares?blueprint=2050044&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo#executive-summary
https://simplywall.st/stocks/ca/software/tsx-syz/sylogist-shares?blueprint=2050044&utm_medium=finance_user&utm_campaign=conclusion-grid&utm_source=yahoo#executive-summary
Q: Can I have your opinion on Canadian Overseas Petroleum LTD, buy hold or sell
Thanks, John
Thanks, John
Q: Are you able to provide your assessment of Curo. The company seems to be very comparable to GOEASY. Would you consider them the same(other than Curo having a stronger presence in the U.S., though they are growing in Canada)?
Q: BABY ... your assessment of the recent deal in china and prospects
Q: Please comment on Q results & guide. It dropped 7.8% to $6.12 thereafter. Bought it in early Aug,2018 @ $9.10 when it was a Top Pick on Market Call. While the current yield is 4.9%,there is expectation of higher rates by BOC. Hold on longer or sell. If sell ,please provide 2or3 good names(not necessary in the same sector). Txs for u usual great services & views
Q: I have TCL.a in a tax-deferred account and show a significant loss — 50.1% below my cost. I cannot use the tax loss. I follow only US shares , and 95% of my folio is in US-listed companies. I do not follow Canadian markets at all and was therefore wondering why on earth I bought this awful entity.
I have no clue EXCEPT since I would buy Canadian shares only if suggested by 5i or if the security appeared in the 5i portfolio.
Was this company EVER in the 5i folio? (I do not check the Q & A section; too many questions contain a bewilderingly long—very long— list of symbols that make it tediously difficult to read).
On TCL.a I checked reports from RBC-DI , iTRADE, Thompson Reuters, Research Team, StockCalc, StockReports, CFRA and several others. RBC is the only analyst that does NOT hate it.
When I took a closer look at TCL.a , I find it has a horribly, outdated business model. It has done nothing for years, and share price has gone only down. No analyst seems to have a clue how this ancient business model can ever work.
What do you think of TCL.a ? It does not matter that I find it maddening, meaning please disregard my prejudices and my frustration with myself for buying, then holding, something I didn’t take time to review. I am looking for a fresh independent opinion.... a very FRESH opinion from you, AFTER it reports tomorrow (June 8).
I have no clue EXCEPT since I would buy Canadian shares only if suggested by 5i or if the security appeared in the 5i portfolio.
Was this company EVER in the 5i folio? (I do not check the Q & A section; too many questions contain a bewilderingly long—very long— list of symbols that make it tediously difficult to read).
On TCL.a I checked reports from RBC-DI , iTRADE, Thompson Reuters, Research Team, StockCalc, StockReports, CFRA and several others. RBC is the only analyst that does NOT hate it.
When I took a closer look at TCL.a , I find it has a horribly, outdated business model. It has done nothing for years, and share price has gone only down. No analyst seems to have a clue how this ancient business model can ever work.
What do you think of TCL.a ? It does not matter that I find it maddening, meaning please disregard my prejudices and my frustration with myself for buying, then holding, something I didn’t take time to review. I am looking for a fresh independent opinion.... a very FRESH opinion from you, AFTER it reports tomorrow (June 8).
Q: Could you comment on the latest contract signed by VHI which equates to about 7% of their market cap? Thanks as always.
TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSX: VHI) is pleased to announce that TREAT has been licensed for an initial six-year contract term and an option to extend for four additional years, to better track the essential medical information needed to effectively treat inmates in provincially-run adult correctional institutions across Ontario.
For VitalHub, this agreement is an important and meaningful event. The six-year contract value is comprised of recurring license revenue and professional services delivered over a six-year period, totaling approximately $9 million (CAD) in the initial term.
TORONTO, June 06, 2022 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSX: VHI) is pleased to announce that TREAT has been licensed for an initial six-year contract term and an option to extend for four additional years, to better track the essential medical information needed to effectively treat inmates in provincially-run adult correctional institutions across Ontario.
For VitalHub, this agreement is an important and meaningful event. The six-year contract value is comprised of recurring license revenue and professional services delivered over a six-year period, totaling approximately $9 million (CAD) in the initial term.
Q: Can you give me a list of some small cap canadian companies who have good balance sheet, debt are not too high and you recommend in investing for the long term
Q: Pennymac would, at first glance, appear to be on the "road to nowhere" in terms of stock price and prospects. However, in Point & Figure terms it is currently in "Triple Top Breakout" mode since May 24 and its cash flow seems more than adequate to meet dividend payout requirements. Is this a decent income stock?
Q: Is Dbm a buy at this level?
Q: Good morning your thoughts on Genco Shipping
-
Main Street Capital Corporation (MAIN)
-
Gladstone Capital Corporation (GLAD)
-
Hercules Capital Inc. (HTGC)
Q: What is your opinion of these equities, in general and in the current environment? Are there any which you would consider for a long-term hold for income/growth? Or sell?
With thanks.
With thanks.
Q: DO YOU THINK IN YOUR OPINIONS IS PROFOUND MEDICAL A VERY GOOD SPECULATIVE BUY?
BRAVO
BRAVO
Q: Stock continues to drift lower.[ down 30%]Would add too a small position in a cash account now or wait?
Q: I like this small-cap, as a long term play in the home builder space. Was there any specific negative news to drive its share price down today, or could this be a potential dip-buying opportunity? Thank you